Related Experiment Video
Updated: Nov 26, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Multiscale classification of heart failure phenotypes by unsupervised clustering of unstructured electronic medical
Tasha Nagamine1, Brian Gillette2,3, Alexey Pakhomov1
1Droice Research, New York, NY, USA.
Insights
This study introduces a novel data-driven method to subgroup heart failure (HF) patients using clinical notes. This approach reveals distinct HF patient profiles for better understanding and treatment.
Area of Science:
- Cardiology
- Medical Informatics
- Computational Biology
Background:
- Heart failure (HF) is a major cause of death and healthcare costs globally.
- Current HF subtyping methods lack precision due to diverse patient factors, limiting clinical decisions and therapy development.
- A data-driven approach is needed to better characterize real-world HF patient heterogeneity.
Purpose of the Study:
- To develop and validate a novel, data-driven methodology for characterizing heart failure patient subpopulations.
- To leverage natural language processing (NLP) and clustering on electronic health record (EHR) data to identify distinct HF patient groups.
- To uncover clinically interpretable subgroups based on patient complaints and manifestations.
Main Methods:
- Utilized NLP to process unstructured clinical notes from EHRs, extracting disease and symptom concepts (complaints).
- Constructed vectorized representations of patient complaints.
- Applied clustering algorithms to group HF patients based on complaint vector similarity and identified enriched complaints within each cluster via statistical testing.
Main Results:
- Successfully clustered heart failure patients into clinically interpretable subgroups based on complaint patterns.
- Identified known HF etiologies, risk factors, and comorbidities (e.g., ischemic heart disease, hypertension, diabetes) within the discovered subgroups.
- Provided deeper insights into the specific clinical manifestations of HF within each identified subgroup.
Conclusions:
- The novel NLP and clustering approach effectively characterizes real-world heart failure patient heterogeneity.
- This hypothesis-free methodology can reveal clinically meaningful HF subgroups and inform personalized treatment strategies.
- The approach is adaptable for discovering novel insights in other diseases and patient populations.
Abstract:
As a leading cause of death and morbidity, heart failure (HF) is responsible for a large portion of healthcare and disability costs worldwide. Current approaches to define specific HF subpopulations may fail to account for the diversity of etiologies, comorbidities, and factors driving disease progression, and therefore have limited value for clinical decision making and development of novel therapies. Here we present a novel and data-driven approach to understand and characterize the real-world manifestation of HF by clustering disease and symptom-related clinical concepts (complaints) captured from unstructured electronic health record clinical notes. We used natural language processing to construct vectorized representations of patient complaints followed by clustering to group HF patients by similarity of complaint vectors. We then identified complaints that were significantly enriched within each cluster using statistical testing. Breaking the HF population into groups of similar patients revealed a clinically interpretable hierarchy of subgroups characterized by similar HF manifestation. Importantly, our methodology revealed well-known etiologies, risk factors, and comorbid conditions of HF (including ischemic heart disease, aortic valve disease, atrial fibrillation, congenital heart disease, various cardiomyopathies, obesity, hypertension, diabetes, and chronic kidney disease) and yielded additional insights into the details of each HF subgroup's clinical manifestation of HF. Our approach is entirely hypothesis free and can therefore be readily applied for discovery of novel insights in alternative diseases or patient populations.
Related Concept Videos
Heart Failure IV: Classification and Diagnostic Evaluation
Pathophysiology of Heart Failure
Heart Failure II: Pathophysiology
Heart Failure I: Introduction
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure III: Clinical Manifestations

